Filing Details
- Accession Number:
- 0001651844-17-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-29 10:01:11
- Reporting Period:
- 2017-03-08
- Filing Date:
- 2017-03-29
- Accepted Time:
- 2017-03-29 10:01:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1018735 | Nymox Pharmaceutical Corp | NYMX | In Vitro & In Vivo Diagnostic Substances (2835) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1651844 | George James Robinson | 10 East Lee Street Suite 2705 Baltimore MD 21202 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-03-08 | 528 | $3.49 | 2,906,078 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-03-08 | 3,500 | $3.50 | 2,911,578 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-03-08 | 114 | $3.53 | 2,911,692 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-03-08 | 900 | $3.54 | 2,912,592 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-03-08 | 100 | $3.57 | 2,912,692 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-03-08 | 900 | $3.58 | 2,913,592 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-03-08 | 110 | $3.59 | 2,913,702 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-03-08 | 43,848 | $3.60 | 2,957,550 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 45,050 | Indirect | Trust |
Common Stock | 45,050 | Indirect | Trust |
Common Stock | 45,050 | Indirect | Trust |
Common Stock | 45,050 | Indirect | Trust |
Common Stock | 45,050 | Indirect | Trust |
Common Stock | 45,050 | Indirect | Trust |
Common Stock | 45,050 | Indirect | Trust |
Common Stock | 45,050 | Indirect | Trust |